|
1.A. Alonso, M. A. Hernan, Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71, 129-135 (2008). 2.D. H. Mahad, B. D. Trapp, H. Lassmann, Pathological mechanisms in progressive multiple sclerosis. The Lancet Neurology 14, 183-193 (2015). 3.B. Weinstock-Guttman, M. Ramanathan, R. Zivadinov, Interferon-beta treatment for relapsing multiple sclerosis. Expert Opin Biol Ther 8, 1435-1447 (2008). 4.L. S. H. W. A. SHEREMATA, Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. (1989). 5.R. A. O'Connor et al., Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 181, 3750-3754 (2008). 6.C. S. Constantinescu, N. Farooqi, K. O'Brien, B. Gran, Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164, 1079-1106 (2011). 7.J. M. Fletcher, S. J. Lalor, C. M. Sweeney, N. Tubridy, K. H. Mills, T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162, 1-11 (2010). 8.R. V. Luckheeram, R. Zhou, A. D. Verma, B. Xia, CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012, 925135 (2012). 9.S. Romagnani, Th1/Th2 cells. Inflamm Bowel Dis 5, 285-294 (1999). 10.G. H. Stummvoll et al., Th1, Th2, and Th17 Effector T Cell-Induced Autoimmune Gastritis Differs in Pathological Pattern and in Susceptibility to Suppression by Regulatory T Cells. The Journal of Immunology 181, 1908-1916 (2008). 11.S. S. Deo, K. J. Mistry, A. M. Kakade, P. V. Niphadkar, Role played by Th2 type cytokines in IgE mediated allergy and asthma. Lung India 27, 66-71 (2010). 12.T. Korn, E. Bettelli, M. Oukka, V. K. Kuchroo, IL-17 and Th17 Cells. Annu Rev Immunol 27, 485-517 (2009). 13.S. Sakaguchi, K. Wing, M. Miyara, Regulatory T cells - a brief history and perspective. Eur J Immunol 37 Suppl 1, S116-123 (2007). 14.J. D. Fontenot, M. A. Gavin, A. Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330-336 (2003). 15.S. Hori, T. Nomura, S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003). 16.C. R. Grant, R. Liberal, G. Mieli-Vergani, D. Vergani, M. S. Longhi, Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions. Autoimmun Rev 14, 105-116 (2015). 17.P. A. Jones, S. B. Baylin, The epigenomics of cancer. Cell 128, 683-692 (2007). 18.M. Okano, D. W. Bell, D. A. Haber, E. Li, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257 (1999). 19.H. Leonhardt, A. W. Page, H. U. Weier, T. H. Bestor, A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71, 865-873 (1992). 20.N. Rivlin, R. Brosh, M. Oren, V. Rotter, Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer 2, 466-474 (2011). 21.B. Suarez-Alvarez, R. M. Rodriguez, M. F. Fraga, C. Lopez-Larrea, DNA methylation: a promising landscape for immune system-related diseases. Trends Genet 28, 506-514 (2012). 22.S. D. Bos et al., Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis. PLoS One 10, e0117403 (2015). 23.P. C. Janson et al., Profiling of CD4+ T cells with epigenetic immune lineage analysis. J Immunol 186, 92-102 (2011). 24.Q. Lu et al., Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 46, 1282-1291 (2002). 25.P. Matatiele, M. Tikly, G. Tarr, M. Gulumian, DNA methylation similarities in genes of black South Africans with systemic lupus erythematosus and systemic sclerosis. J Biomed Sci 22, 34 (2015). 26.N. J. Bernard, Rheumatoid arthritis: Who knows why regulatory T cells are defective in RA ... IDO. Nat Rev Rheumatol 10, 381 (2014). 27.J. K. Wiencke et al., The DNA methylation profile of activated human natural killer cells. Epigenetics 11, 363-380 (2016). 28.R. C. Hardison, Conserved noncoding sequences are reliable guides to regulatory elements. Trends Genet 16, 369-372 (2000). 29.J. R. Schoenborn et al., Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat Immunol 8, 732-742 (2007). 30.G. R. Lee, S. T. Kim, C. G. Spilianakis, P. E. Fields, R. A. Flavell, T helper cell differentiation: regulation by cis elements and epigenetics. Immunity 24, 369-379 (2006). 31.R. D. Hatton et al., A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25, 717-729 (2006). 32.A. Balasubramani et al., Deletion of a conserved cis-element in the Ifng locus highlights the role of acute histone acetylation in modulating inducible gene transcription. PLoS Genet 10, e1003969 (2014). 33.J. K. Polansky et al., DNA methylation controls Foxp3 gene expression. Eur J Immunol 38, 1654-1663 (2008). 34.R. M. Thomas, H. Sai, A. D. Wells, Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus. J Biol Chem 287, 25049-25059 (2012). 35.K. Raj, G. J. Mufti, Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes. Ther Clin Risk Manag 2, 377-388 (2006). 36.S. F. Ziegler, J. H. Buckner, FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 11, 594-598 (2009). 37.M. Kleinewietfeld, D. A. Hafler, The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 25, 305-312 (2013). 38.M. W. Chan et al., Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells. Mol Med 20, 248-256 (2014). 39.B. Jones, J. Chen, Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 25, 2443-2452 (2006). 40.C. M. Tato et al., Cutting Edge: Innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter. J Immunol 173, 1514-1517 (2004). 41.M. Inoue et al., Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci Signal 5, ra38 (2012). 42.G. Arellano, P. A. Ottum, L. I. Reyes, P. I. Burgos, R. Naves, Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol 6, 492 (2015). 43.S. S. Yoshinobu Okuda , Takehiko Yanagihara, The pattern of cytokine gene expression in lymphoid organs and peripheral blood mononuclear cells of mice with experimental allergic encephalomyelitis. Journal of Neuroimmunology, (1998).
|